BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 16123592)

  • 1. The acidic tail domain of human Cdc34 is required for p27Kip1 ubiquitination and complementation of a cdc34 temperature sensitive yeast strain.
    Block K; Appikonda S; Lin HR; Bloom J; Pagano M; Yew PR
    Cell Cycle; 2005 Oct; 4(10):1421-7. PubMed ID: 16123592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cdc34 C-terminal tail phosphorylation regulates Skp1/cullin/F-box (SCF)-mediated ubiquitination and cell cycle progression.
    Sadowski M; Mawson A; Baker R; Sarcevic B
    Biochem J; 2007 Aug; 405(3):569-81. PubMed ID: 17461777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The acidic tail of the Cdc34 ubiquitin-conjugating enzyme functions in both binding to and catalysis with ubiquitin ligase SCFCdc4.
    Kleiger G; Hao B; Mohl DA; Deshaies RJ
    J Biol Chem; 2009 Dec; 284(52):36012-36023. PubMed ID: 19875449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis for lysine specificity in the yeast ubiquitin-conjugating enzyme Cdc34.
    Sadowski M; Suryadinata R; Lai X; Heierhorst J; Sarcevic B
    Mol Cell Biol; 2010 May; 30(10):2316-29. PubMed ID: 20194622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a portable determinant of cell cycle function within the carboxyl-terminal domain of the yeast CDC34 (UBC3) ubiquitin conjugating (E2) enzyme.
    Kolman CJ; Toth J; Gonda DK
    EMBO J; 1992 Aug; 11(8):3081-90. PubMed ID: 1639075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CK2 phosphorylation of catalytic domain of Cdc34 modulates its activity at the G1 to S transition in Saccharomyces cerevisiae.
    Coccetti P; Tripodi F; Tedeschi G; Nonnis S; Marin O; Fantinato S; Cirulli C; Vanoni M; Alberghina L
    Cell Cycle; 2008 May; 7(10):1391-401. PubMed ID: 18418079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The human Cdc34 carboxyl terminus contains a non-covalent ubiquitin binding activity that contributes to SCF-dependent ubiquitination.
    Choi YS; Wu K; Jeong K; Lee D; Jeon YH; Choi BS; Pan ZQ; Ryu KS; Cheong C
    J Biol Chem; 2010 Jun; 285(23):17754-62. PubMed ID: 20353940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel CDC34 (UBC3) ubiquitin-conjugating enzyme mutants obtained by charge-to-alanine scanning mutagenesis.
    Pitluk ZW; McDonough M; Sangan P; Gonda DK
    Mol Cell Biol; 1995 Mar; 15(3):1210-9. PubMed ID: 7862115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct characterization of E2-dependent target specificity and processivity using an artificial p27-linker-E2 ubiquitination system.
    Ryu KS; Choi YS; Ko J; Kim SO; Kim HJ; Cheong HK; Jeon YH; Choi BS; Cheong C
    BMB Rep; 2008 Dec; 41(12):852-7. PubMed ID: 19123975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Release of ubiquitin-charged Cdc34-S - Ub from the RING domain is essential for ubiquitination of the SCF(Cdc4)-bound substrate Sic1.
    Deffenbaugh AE; Scaglione KM; Zhang L; Moore JM; Buranda T; Sklar LA; Skowyra D
    Cell; 2003 Sep; 114(5):611-22. PubMed ID: 13678584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimodal mechanism of action for the Cdc34 acidic loop: a case study for why ubiquitin-conjugating enzymes have loops and tails.
    Ziemba A; Hill S; Sandoval D; Webb K; Bennett EJ; Kleiger G
    J Biol Chem; 2013 Nov; 288(48):34882-96. PubMed ID: 24129577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human ubiquitin-conjugating enzyme Cdc34 controls cellular proliferation through regulation of p27Kip1 protein levels.
    Butz N; Ruetz S; Natt F; Hall J; Weiler J; Mestan J; Ducarre M; Grossenbacher R; Hauser P; Kempf D; Hofmann F
    Exp Cell Res; 2005 Feb; 303(2):482-93. PubMed ID: 15652359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SCF E3-mediated autoubiquitination negatively regulates activity of Cdc34 E2 but plays a nonessential role in the catalytic cycle in vitro and in vivo.
    Scaglione KM; Bansal PK; Deffenbaugh AE; Kiss A; Moore JM; Korolev S; Cocklin R; Goebl M; Kitagawa K; Skowyra D
    Mol Cell Biol; 2007 Aug; 27(16):5860-70. PubMed ID: 17562869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Cdc34/SCF ubiquitination complex mediates Saccharomyces cerevisiae cell wall integrity.
    Varelas X; Stuart D; Ellison MJ; Ptak C
    Genetics; 2006 Dec; 174(4):1825-39. PubMed ID: 17028344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cdc34 self-association is facilitated by ubiquitin thiolester formation and is required for its catalytic activity.
    Varelas X; Ptak C; Ellison MJ
    Mol Cell Biol; 2003 Aug; 23(15):5388-400. PubMed ID: 12861024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intragenic suppression among CDC34 (UBC3) mutations defines a class of ubiquitin-conjugating catalytic domains.
    Liu Y; Mathias N; Steussy CN; Goebl MG
    Mol Cell Biol; 1995 Oct; 15(10):5635-44. PubMed ID: 7565715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insight into the role of the Cdc34 ubiquitin-conjugating enzyme in cell cycle regulation via Ace2 and Sic1.
    Cocklin R; Heyen J; Larry T; Tyers M; Goebl M
    Genetics; 2011 Mar; 187(3):701-15. PubMed ID: 21196523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a diffusion-driven mechanism for substrate ubiquitination by the SCF-Cdc34 ubiquitin ligase complex.
    Petroski MD; Kleiger G; Deshaies RJ
    Mol Cell; 2006 Nov; 24(4):523-34. PubMed ID: 17114057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation of the human ubiquitin-conjugating enzyme, CDC34, by casein kinase 2.
    Block K; Boyer TG; Yew PR
    J Biol Chem; 2001 Nov; 276(44):41049-58. PubMed ID: 11546811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a dominant negative mutant of the cell cycle ubiquitin-conjugating enzyme Cdc34.
    Banerjee A; Deshaies RJ; Chau V
    J Biol Chem; 1995 Nov; 270(44):26209-15. PubMed ID: 7592826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.